MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium - Guo, Robin; Berry, Lynne D.; Aisner, Dara L.; Sheren, Jamie; Boyle, Theresa; Bunn, Paul A.; Johnson, Bruce E.; Kwiatkowski, David J.; Drilon, Alexander; Sholl, Lynette M.; Kris, Mark G. (Journal of thoracic oncology, 2019)
Keywords: FISH; Immunohistochemistry; Lung cancer; MET exon 14; MET-amplified; Next-generation sequencing; Immunohistochemistry; FISH; Next-generation sequencing; MET-amplified; MET exon 14; Lung cancer